INMD stock featured on Mad Money by Jim Cramer – Off the Charts
INMD stock featured on Mad Money by Jim Cramer – Off the Charts
With the rise of medtech stocks soaring every day, Mad Money’s Jim Cramer profiles InMode (Nasdaq: INMD) on his “Off the Charts” segment, as the best of medical aesthetics stocks. InMode is a “fresh face” stock that Jim recommended in October 2019 at $24, and has risen sharply, now sitting at $46. The stock has rallied 75% in a couple of months, and Jim still thinks there is room for growth, saying “its possible that InMode can go to $75 or $80. It is the ideal pick for the Instagram era.”
